Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...
Guardado en:
Autores principales: | Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Leo Hanke, et al.
Publicado: (2020) -
Investigating the Concerns of First-Time Distance Education Instructors
por: Halil Kayaduman, et al.
Publicado: (2019) -
Model-Based Prediction of an Effective Adhesion Parameter Guiding Multi-Type Cell Segregation
por: Philipp Rossbach, et al.
Publicado: (2021) -
Examining the Relative Influence of Risk and Control on Intention to Adopt Risky Technologies
por: Gupta,Sumeet, et al.
Publicado: (2010) -
Mapping Population Distribution Based on XGBoost Using Multisource Data
por: Xin Zhao, et al.
Publicado: (2021)